Tag:
NovImmune
Latest Headlines
Latest Headlines
NovImmune raises $20.7M for mAb work
BZ Bank Aktiengesellschaft has led a $20.7 million Series B round of financing Geneva-based NovImmune. The company is developing therapeutic monoclonal antibodies for inflammatory diseases and
NovImmune inks deal, eyes possible IPO
Genentech has forged a licensing pact with Geneva-based NovImmune for an early-stage IL-17 antibody that may be useful in treating inflammatory and autoimmune diseases. And the Swiss biotech, which
NovImmune raises $54.8M to buy back drug rights
Switzerland's NovImmune has rounded up $54.8 million (CHF 62.5 million) to take back control of its lead compounds NI-0401 and NI-0501 from MerckSerono. The company said the money will also be used
